4626 related articles for article (PubMed ID: 29327896)
21. Predictors of non-alcoholic fatty liver disease in obese children.
Sartorio A; Del Col A; Agosti F; Mazzilli G; Bellentani S; Tiribelli C; Bedogni G
Eur J Clin Nutr; 2007 Jul; 61(7):877-83. PubMed ID: 17151586
[TBL] [Abstract][Full Text] [Related]
22. Ultrasound Grade of Liver Steatosis Is Independently Associated with the Risk of Metabolic Syndrome.
Mustapic S; Ziga S; Matic V; Bokun T; Radic B; Lucijanic M; Marusic S; Babic Z; Grgurevic I
Can J Gastroenterol Hepatol; 2018; 2018():8490242. PubMed ID: 30211140
[TBL] [Abstract][Full Text] [Related]
23. Non alcoholic fatty liver disease in a Nigerian population with type II diabetes mellitus.
Olusanya TO; Lesi OA; Adeyomoye AA; Fasanmade OA
Pan Afr Med J; 2016; 24():20. PubMed ID: 27583084
[TBL] [Abstract][Full Text] [Related]
24. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].
Choi SY; Kim D; Kang JH; Park MJ; Kim YS; Lim SH; Kim CH; Lee HS
Korean J Hepatol; 2008 Mar; 14(1):77-88. PubMed ID: 18367860
[TBL] [Abstract][Full Text] [Related]
25. The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children.
El-Koofy NM; Anwar GM; El-Raziky MS; El-Hennawy AM; El-Mougy FM; El-Karaksy HM; Hassanin FM; Helmy HM
Saudi J Gastroenterol; 2012; 18(1):44-9. PubMed ID: 22249092
[TBL] [Abstract][Full Text] [Related]
26. [Lipid metabolism in non-alcoholic fatty liver disease in patients with different body weights in mid-mountain conditions].
Toktogulova NA; Sultanalieva RB; Tuhvatshin RR; Kaliev TK
Ter Arkh; 2023 Jan; 94(12):1361-1366. PubMed ID: 37167179
[TBL] [Abstract][Full Text] [Related]
27. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
[TBL] [Abstract][Full Text] [Related]
28. Interrelation of the Risk Factors of NAFLD at various Stages of Progression of the glycemic Status on long-term Follow-up.
Ray G; Kumar C
J Assoc Physicians India; 2022 Jun; 70(6):11-12. PubMed ID: 35702836
[TBL] [Abstract][Full Text] [Related]
29. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.
Oh SY; Cho YK; Kang MS; Yoo TW; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH
Metabolism; 2006 Dec; 55(12):1604-9. PubMed ID: 17142131
[TBL] [Abstract][Full Text] [Related]
30. Erosive esophagitis associated with metabolic syndrome, impaired liver function, and dyslipidemia.
Loke SS; Yang KD; Chen KD; Chen JF
World J Gastroenterol; 2013 Sep; 19(35):5883-8. PubMed ID: 24124334
[TBL] [Abstract][Full Text] [Related]
31. Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study.
Grattagliano I; Ubaldi E; Napoli L; Marulli CF; Nebiacolombo C; Cottone C; Portincasa P
Ann Hepatol; 2013; 12(1):70-7. PubMed ID: 23293196
[TBL] [Abstract][Full Text] [Related]
32. Relationship between ultrasound features of nonalcoholic fatty liver disease and cardiometabolic risk factors in patients with newly diagnosed type 2 diabetes.
Kosmalski M; Kasznicki J; Drzewoski J
Pol Arch Med Wewn; 2013; 123(9):436-42. PubMed ID: 23792440
[TBL] [Abstract][Full Text] [Related]
33. Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: a cross-sectional case-control study.
Lee S; Jin Kim Y; Yong Jeon T; Hoi Kim H; Woo Oh S; Park Y; Soo Kim S
Scand J Gastroenterol; 2006 May; 41(5):566-72. PubMed ID: 16638699
[TBL] [Abstract][Full Text] [Related]
34. Non-alcoholic fatty liver disease and its associations among adolescents in an urban, Sri Lankan community.
Rajindrajith S; Pathmeswaran A; Jayasinghe C; Kottahachchi D; Kasturiratne A; de Silva ST; Niriella MA; Dassanayake AS; de Silva AP; de Silva HJ
BMC Gastroenterol; 2017 Nov; 17(1):135. PubMed ID: 29187144
[TBL] [Abstract][Full Text] [Related]
35. Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease.
Gelli C; Tarocchi M; Abenavoli L; Di Renzo L; Galli A; De Lorenzo A
World J Gastroenterol; 2017 May; 23(17):3150-3162. PubMed ID: 28533672
[TBL] [Abstract][Full Text] [Related]
36. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
[TBL] [Abstract][Full Text] [Related]
37. Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease.
van den Berg EH; Gruppen EG; Ebtehaj S; Bakker SJL; Tietge UJF; Dullaart RPF
Atherosclerosis; 2018 Oct; 277():21-27. PubMed ID: 30170220
[TBL] [Abstract][Full Text] [Related]
38. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of metabolic syndrome and non-alcoholic fatty liver disease in a cohort of italian patients with spinal-bulbar muscular atrophy.
Francini-Pesenti F; Querin G; Martini C; Mareso S; Sacerdoti D
Acta Myol; 2018 Sep; 37(3):204-209. PubMed ID: 30838350
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease.
Bi Y; Min M; Shen W; Deng P; Du Q; Dong M; Liu Y
Int J Clin Exp Pathol; 2015; 8(7):8494-9. PubMed ID: 26339423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
